1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical and radiologic characteristics of the patients
Characteristics Men (No.) (%) 23 (65.7) Age (mean) (SD) (yr) 72.2 (12.8) Hypertension (No.) (%) 17 (48.6) Diabetes mellitus (No.) (%) 5 (14.3) Dyslipidemia (No.) (%) 10 (28.6) Previous ischemic stroke (No.) (%) 4 (11.4) Previous ICH (No.) (%) 2 (5.7) Coronary artery disease (No.) (%) 3 (8.6) Atrial fibrillation (No.) (%) 4 (11.4) Glomerular filtration rate <30 mL/min (No.) (%) 2 (5.7) Alcohol abuse (>80 g/day) (No.) (%) 1 (2.9) Smoking (No.) (%) 7 (20) Liver disease (No.) (%) 1 (2.9) Prior antiplatelet therapy (No.) (%) 6 (17.1) Previous use of oral anticoagulants (No.) (%) 4 (11.4) Previous use of atorvastatin (No.) (%) 3 (8.6) NIHSS score at admission (median) (IQR) 11 (3.5–19) GCS at admission (median) (IQR) 15 (13–15) Systolic blood pressure (mean) (SD) (mm Hg) 168.1 (32.8) Blood glucose level (mean) (SD) (mg/dL) 137.8 (47.5) Platelet count/mm3 (mean) (SD) 220,469 (75,971) Lobar ICH (No.) (%) 16 (45.7) IVH (No.) (%) 10 (28.6) HV (mL) (median) (IQR) 9.85 (2.74–68.29)
Note:—GCS indicates Glasgow Coma Scale; IVH, intraventricular hemorrhage.